Form 8-K · Current Report · Filed 2026-06-01
Humana Inc. Reaffirms FY 2026 Earnings Guidance
Humana Inc. has reaffirmed its guidance for diluted earnings per share (EPS) of at least $8.36 and adjusted EPS of at least $9.00 for the year ending December 31, 2026. This guidance is consistent with the company's previous announcement on April 29, 2026. The company uses adjusted EPS, a non-GAAP measure, to provide a more comprehensive perspective on its core operating performance. The guidance excludes the impact of value changes to items that have not yet been recognized or cannot currently be reasonably estimated.
- Filer
- Humana Inc. HUM · NYSE
- Filed
- Accession
- 0000049071-26-000027
- CIK
- 0000049071
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$305.42
Next session
+5.1%
Since filing
+19.1%
Latest close
$363.86
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from HUM reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, HUM insiders reported 1 Form 4 transaction — net buying of $91K.
About Humana Inc.
Humana Inc. is a leading healthcare insurance company that primarily focuses on offering comprehensive health insurance products and services. It operates in the insurance sector and is a significant player in the Medicare Advantage market, providing coverage solutions for senior citizens eligible for Medicare. Additionally, Humana boasts a diverse range of health plans, including individual, group medical plans, and specialty products like dental and vision care. The company extends its services to various sectors, including government-sponsored healthcare programs and commercial employers, emphasizing wellness and preventive care. Humana’s offerings are designed to meet the needs of both individual consumers and large organizations, ensuring tailored healthcare coverage. Based in Louisville, Kentucky, Humana is a crucial component of the healthcare system in the United States, striving to improve health outcomes and provide affordable insurance options. The company continues to influence the healthcare industry by enhancing its digital solutions and fostering partnerships that promote integrated care between medical professionals and insurers.
Never miss another HUM filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.